Lei Chen
Direktor/Vorstandsmitglied bei SHANGHAI XFH TECHNOLOGY CO., LTD
Profil
Lei Chen is currently a Director at Shanghai XFH Technology Co., Ltd.
and Beijing Shenogen Pharma Group Ltd.
He graduated from Tsinghua University in 2005.
Aktive Positionen von Lei Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| SHANGHAI XFH TECHNOLOGY CO., LTD | Direktor/Vorstandsmitglied | 20.01.2016 |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | - |
Ausbildung von Lei Chen
| Tsinghua University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHANGHAI XFH TECHNOLOGY CO., LTD | Producer Manufacturing |
| Private Unternehmen | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
